Paul Slosar, MD, MHCDS is an orthopedic spine surgeon who practiced for 28 years in the San Francisco Bay area. He served as Administrative Partner and President of the group from 2007-2020. Dr. Slosar also served as the Medical Director of the Spine Care Institute of San Francisco and Director of Surgical Research at the San Francisco Spine Institute.

Dr. Slosar is a Partner in 46 Venture Capital, a multi-fund manager focusing on early-stage investments across multiple sectors. He is a Co-founder and General Partner in their Physicians Capital Fund, launched in 2024, anchored by physician investors focusing on accelerating innovation in healthcare companies.

Dr. Slosar has been recognized as one of the Top 100 Spine Surgeons in the United States by Becker’s Orthopedic and Spine Review, as well as a Super Doctor ® of San Francisco. He has been named to the prestigious U.S. News & World Report®/Castle Connolly Top Doctor® list consecutively from 2013-2023.

In 2008, Dr. Slosar became the Chief Medical Officer for Titan Spine, which was acquired by Medtronic in 2019. As the CMO, he provided the company with strategic guidance on spinal implant nano-surface technology development, research publications, as well as interaction with CMS and the FDA. In this capacity, Dr. Slosar has emerged as national expert and frequent lecturer on the topic of emerging spinal implant technologies. He remains a strategy consultant for the Medtronic Neurosciences executive team and is the chairman of their nanotechnology advisory board. From 2020-2023 Dr. Slosar was the Chief Medical Officer for Episode Solutions, a Nashville-based industry leader in value-based health care and bundled payments.

Dr. Slosar’s 11-year tenure as CMO of Titan Spine, LLC was pivotal in positioning the company for acquisition by Medtronic in 2019. He has also been a strategic advisor to several other companies which have had successful exits, or acquisitions, including Kyphon (acquired in 2007 by Medtronic) Surgical Care Affiliates (acquired in 2017 by United Health Care/ Optum), and Relievant (acquired in 2023 by Boston Scientific). In 2021, Dr. Slosar founded PS/md Consul9ng LLC, providing advisory services to physician practices and healthcare companies.

Dr. Slosar holds a Master of Health Care Delivery Science from Dartmouth College, an MD from Rush University, and an Intensive Seminar Cer9ficate in Value Based Health Care from Harvard Business School.